Silexion Therapeutics Executes 1-for-10 Reverse Stock Split

Silexion Therapeutics Corp. has finalized a 1-for-10 reverse stock split for its ordinary shares, effective May 28, 2026. Trading under the adjusted terms commenced on May 29, 2026, using the same ticker symbol. This corporate action was implemented to help the company meet Nasdaq's minimum bid price requirements.